他汀類藥物調(diào)脂外作用在臨床應(yīng)用的研究進(jìn)展-文庫吧資料
2024-08-17 13:55本頁面
【正文】 ardiol，2010，105（3）：283—287.[15] wilt t j，bloomfield h e，macdonald r，et of statin therapy in adults with coronary heart disease[j].arch intern med，2004，164（13）：1427—1436.[16] amarenco p，bogousslavsky j，callahan a，et prevention by aggressive reduction in cholesterol levels （sparcl） investigators. high—dose atorvastatin after stroke or transient ischemic attack[j].n engl j med，2006，355（6）：549—559.[17] byington r p，davis b r，plehn j f，et of stroke events with pravastatin： the prospective pravastatin pooling （ppp） project[j].circulation，2001，103（3）：387—392.[18] guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack：a statement for healthcare professionals from the american heart association/american stroke association council on stroke： co—sponsored by the council on cardiovascular radiology and intervention：the american academy of neurology affirms the value of this guideline[j].stroke，2006，37（2）：577—617.[19] deedwania p c，javed in heart failure[j].cardiol clin，2008，26（4）：573—587.[20] the corona investigators. rosuvastatin in older patients with systolic heart failure[j].n engl j med，2007，357（22）：2248—2261.[21] gissi—hf of rosuvastatin in patients with chronic heart failure （the gissi—hf trial）： a randomised， double—blind， placebocontrolled trial[j].lancet，2008，372（9645）：1231—1239.[22] vyas a k，guo h， moss a j，et in ventricular tachyarrhythmias with statins in the multicenter automatic defibrillator implantation trial （madit）—ii[j].j am coll cardiol，2006，47（4）：769—773.[23] goldberger j j，subacius h，schaechter a，et of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy[j].j am coll cardiol，2006，48（6）：1228—1233.[24] hanna i r，heeke b， bush h，et —lowering drug use is associated with reduced prevalence of atrial fibrillation in patients with left ventricular systolic dysfunction[j].heart rhythm，2006，3（8）：881—886.[25] heart protection study collaborative trial of the effects of cholesterol—lowering with simvastatin on peripheral vascular and other major vascular outes in 20，536 people with peripheral arterial disease and other high—risk conditions[j].j vasc surg，2007，45（4）：645—654.[26] giri j，mcdermott m m，greenland p，et al. statin use and functional decline in patients with and without peripheral arterial disease[j].j am coll cardiol，2006，47（5）：998—1004.[27] aronow w s，nayak d，woodworth s，et of simvastatin versus placebo on treadmill exercise time until the onset of intermittent claudication
環(huán)評(píng)公示相關(guān)推薦
鄂ICP備17016276號(hào)-1